Traders Eye Protalix BioTherapeutics (PLX) Ahead of FDA PDUFA Date
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.59 +0.06 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $1.11 | |||
| Open | $2.51 | 52 Week Low | $0.41 | |||
| Day High | $2.62 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $-0.29 | |||
| Volume | 441,727 | |||||
